• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食蟹猴对尼帕病毒和亨德拉病毒病的抵抗力与细胞介导免疫和体液免疫相关。

Resistance of Cynomolgus Monkeys to Nipah and Hendra Virus Disease Is Associated With Cell-Mediated and Humoral Immunity.

作者信息

Prasad Abhishek N, Woolsey Courtney, Geisbert Joan B, Agans Krystle N, Borisevich Viktoriya, Deer Daniel J, Mire Chad E, Cross Robert W, Fenton Karla A, Broder Christopher C, Geisbert Thomas W

机构信息

Galveston National Laboratory, University of Texas Medical Branch, Galveston.

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston.

出版信息

J Infect Dis. 2020 May 11;221(Suppl 4):S436-S447. doi: 10.1093/infdis/jiz613.

DOI:10.1093/infdis/jiz613
PMID:32022850
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7213570/
Abstract

BACKGROUND

The henipaviruses, Hendra virus (HeV) and Nipah virus (NiV), are capable of causing severe and often lethal respiratory and/or neurologic disease in animals and humans. Given the sporadic nature of henipavirus outbreaks, licensure of vaccines and therapeutics for human use will likely require demonstration of efficacy in animal models that faithfully reproduce the human condition. Currently, the African green monkey (AGM) best mimics human henipavirus-induced disease.

METHODS

The pathogenic potential of HeV and both strains of NiV (Malaysia, Bangladesh) was assessed in cynomolgus monkeys and compared with henipavirus-infected historical control AGMs. Multiplex gene and protein expression assays were used to compare host responses.

RESULTS

In contrast to AGMs, in which henipaviruses cause severe and usually lethal disease, HeV and NiVs caused only mild or asymptomatic infections in macaques. All henipaviruses replicated in macaques with similar kinetics as in AGMs. Infection in macaques was associated with activation and predicted recruitment of cytotoxic CD8+ T cells, Th1 cells, IgM+ B cells, and plasma cells. Conversely, fatal outcome in AGMs was associated with aberrant innate immune signaling, complement dysregulation, Th2 skewing, and increased secretion of MCP-1.

CONCLUSION

The restriction factors identified in macaques can be harnessed for development of effective countermeasures against henipavirus disease.

摘要

背景

亨尼帕病毒,包括亨德拉病毒(HeV)和尼帕病毒(NiV),能够在动物和人类中引发严重且往往致命的呼吸道和/或神经系统疾病。鉴于亨尼帕病毒爆发具有散发性,人类用疫苗和治疗药物的获批可能需要在能如实再现人类病情的动物模型中证明其有效性。目前,非洲绿猴(AGM)最能模拟人类亨尼帕病毒引发的疾病。

方法

在食蟹猴中评估了HeV以及两种NiV毒株(马来西亚株、孟加拉国株)的致病潜力,并与感染亨尼帕病毒的历史对照AGM进行比较。采用多重基因和蛋白质表达分析来比较宿主反应。

结果

与AGM不同,在AGM中亨尼帕病毒会引发严重且通常致命的疾病,而HeV和NiV在猕猴中仅引起轻度或无症状感染。所有亨尼帕病毒在猕猴中的复制动力学与在AGM中相似。猕猴感染与细胞毒性CD8 + T细胞、Th1细胞、IgM + B细胞和浆细胞的激活及预测的募集有关。相反,AGM的致命结局与异常的固有免疫信号传导、补体失调、Th2偏向以及MCP - 1分泌增加有关。

结论

在猕猴中鉴定出的限制因素可用于开发针对亨尼帕病毒疾病的有效对策。

相似文献

1
Resistance of Cynomolgus Monkeys to Nipah and Hendra Virus Disease Is Associated With Cell-Mediated and Humoral Immunity.食蟹猴对尼帕病毒和亨德拉病毒病的抵抗力与细胞介导免疫和体液免疫相关。
J Infect Dis. 2020 May 11;221(Suppl 4):S436-S447. doi: 10.1093/infdis/jiz613.
2
Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection.高效的反向遗传学揭示了尼帕病毒和亨德拉病毒之间出芽和融合差异的遗传决定因素,并能够在亨尼帕病毒感染的小动物模型中实时监测病毒传播。
J Virol. 2015 Jan 15;89(2):1242-53. doi: 10.1128/JVI.02583-14. Epub 2014 Nov 12.
3
Protection against henipaviruses in swine requires both, cell-mediated and humoral immune response.猪对抗亨尼帕病毒需要细胞介导免疫反应和体液免疫反应。
Vaccine. 2016 Sep 14;34(40):4777-86. doi: 10.1016/j.vaccine.2016.08.028. Epub 2016 Aug 17.
4
Prefusion stabilization of the Hendra and Langya virus F proteins.亨德拉病毒和琅琊病毒F蛋白的融合前稳定化
J Virol. 2024 Feb 20;98(2):e0137223. doi: 10.1128/jvi.01372-23. Epub 2024 Jan 12.
5
Hendra virus and Nipah virus animal vaccines.亨德拉病毒和尼帕病毒动物疫苗。
Vaccine. 2016 Jun 24;34(30):3525-34. doi: 10.1016/j.vaccine.2016.03.075. Epub 2016 May 4.
6
Indiscriminate activities of different henipavirus polymerase complex proteins allow for efficient minigenome replication in hybrid systems.不同亨尼帕病毒聚合酶复合蛋白的随意活动使得在杂交系统中能高效进行微型基因组复制。
J Virol. 2024 Jun 13;98(6):e0050324. doi: 10.1128/jvi.00503-24. Epub 2024 May 23.
7
Indirect ELISA based on Hendra and Nipah virus proteins for the detection of henipavirus specific antibodies in pigs.基于亨德拉和尼帕病毒蛋白的间接 ELISA 检测猪体内尼帕病毒特异性抗体。
PLoS One. 2018 Apr 30;13(4):e0194385. doi: 10.1371/journal.pone.0194385. eCollection 2018.
8
Hendra and Nipah infection: emerging paramyxoviruses.亨德拉和尼帕病毒感染:新兴副黏病毒。
Virus Res. 2013 Nov 6;177(2):119-26. doi: 10.1016/j.virusres.2013.08.002. Epub 2013 Aug 13.
9
A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment.一种新型致命亨德拉病毒感染非洲绿猴模型及利巴韦林治疗效果。
J Virol. 2010 Oct;84(19):9831-9. doi: 10.1128/JVI.01163-10. Epub 2010 Jul 21.
10
Animal challenge models of henipavirus infection and pathogenesis.动物挑战模型在亨德拉尼帕病毒感染和发病机制中的应用。
Curr Top Microbiol Immunol. 2012;359:153-77. doi: 10.1007/82_2012_208.

引用本文的文献

1
Successful Inactivation of High-Consequence Pathogens in PrimeStore Molecular Transport Media.在PrimeStore分子转运介质中成功灭活高致病性病原体
Viruses. 2025 Apr 29;17(5):639. doi: 10.3390/v17050639.
2
The oral drug obeldesivir protects nonhuman primates against lethal Ebola virus infection.口服药物瑞德西韦可保护非人灵长类动物免受致命埃博拉病毒感染。
Sci Adv. 2025 Mar 14;11(11):eadw0659. doi: 10.1126/sciadv.adw0659.
3
Oral obeldesivir provides postexposure protection against Marburg virus in nonhuman primates.口服瑞德西韦可为非人灵长类动物提供马尔堡病毒暴露后保护。
Nat Med. 2025 Apr;31(4):1303-1311. doi: 10.1038/s41591-025-03496-y. Epub 2025 Jan 13.
4
Henipaviruses: epidemiology, ecology, disease, and the development of vaccines and therapeutics.亨尼帕病毒:流行病学、生态学、疾病以及疫苗和治疗方法的发展
Clin Microbiol Rev. 2025 Mar 13;38(1):e0012823. doi: 10.1128/cmr.00128-23. Epub 2024 Dec 23.
5
Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control.新发和再发传染病:全球趋势及预防和控制新策略。
Signal Transduct Target Ther. 2024 Sep 11;9(1):223. doi: 10.1038/s41392-024-01917-x.
6
Recent Advances in Immunological Landscape and Immunotherapeutic Agent of Nipah Virus Infection.尼帕病毒感染的免疫景观和免疫治疗剂的最新进展。
Cell Biochem Biophys. 2024 Dec;82(4):3053-3069. doi: 10.1007/s12013-024-01424-4. Epub 2024 Jul 25.
7
Monoclonal antibody therapy protects nonhuman primates against mucosal exposure to Lassa virus.单克隆抗体疗法可保护非人灵长类动物免受拉沙病毒的黏膜暴露。
Cell Rep Med. 2024 Feb 20;5(2):101392. doi: 10.1016/j.xcrm.2024.101392. Epub 2024 Jan 26.
8
Monoclonal antibody therapy demonstrates increased virulence of a lineage VII strain of Lassa virus in nonhuman primates.单克隆抗体疗法显示出拉沙病毒 VII 谱系株在非人灵长类动物中的毒力增强。
Emerg Microbes Infect. 2024 Dec;13(1):2301061. doi: 10.1080/22221751.2023.2301061. Epub 2024 Jan 22.
9
A Survey of Henipavirus Tropism-Our Current Understanding from a Species/Organ and Cellular Level.亨尼帕病毒嗜性概述:从物种/器官和细胞水平看我们目前的理解。
Viruses. 2023 Oct 4;15(10):2048. doi: 10.3390/v15102048.
10
Animal Models for Henipavirus Research.动物模型在亨德拉尼帕病毒研究中的应用。
Viruses. 2023 Sep 22;15(10):1980. doi: 10.3390/v15101980.

本文引用的文献

1
An Intranasal Exposure Model of Lethal Nipah Virus Infection in African Green Monkeys.尼帕病毒经鼻腔感染非洲绿猴致死模型的建立。
J Infect Dis. 2020 May 11;221(Suppl 4):S414-S418. doi: 10.1093/infdis/jiz391.
2
A Lethal Aerosol Exposure Model of Nipah Virus Strain Bangladesh in African Green Monkeys.尼帕病毒孟加拉株在非洲绿猴中的致死性气溶胶暴露模型。
J Infect Dis. 2020 May 11;221(Suppl 4):S431-S435. doi: 10.1093/infdis/jiz469.
3
Peripheral immune response in the African green monkey model following Nipah-Malaysia virus exposure by intermediate-size particle aerosol.尼帕-马来西亚病毒经中间大小颗粒气溶胶暴露后在非洲绿猴模型中的外周免疫反应。
PLoS Negl Trop Dis. 2019 Jun 5;13(6):e0007454. doi: 10.1371/journal.pntd.0007454. eCollection 2019 Jun.
4
Use of Single-Injection Recombinant Vesicular Stomatitis Virus Vaccine to Protect Nonhuman Primates Against Lethal Nipah Virus Disease.使用单次注射重组水疱性口炎病毒疫苗来保护非人灵长类动物免受尼帕病毒病的致死性影响。
Emerg Infect Dis. 2019 Jun;25(6):1144-1152. doi: 10.3201/eid2506.181620.
5
Transmission of Nipah Virus - 14 Years of Investigations in Bangladesh.尼帕病毒传播——孟加拉国 14 年的调查研究。
N Engl J Med. 2019 May 9;380(19):1804-1814. doi: 10.1056/NEJMoa1805376.
6
Nipah Virus Infection of Immature Dendritic Cells Increases Its Transendothelial Migration Across Human Brain Microvascular Endothelial Cells.未成熟树突状细胞的尼帕病毒感染增加其跨人脑微血管内皮细胞的跨内皮迁移。
Front Microbiol. 2018 Nov 13;9:2747. doi: 10.3389/fmicb.2018.02747. eCollection 2018.
7
Aerosol exposure to intermediate size Nipah virus particles induces neurological disease in African green monkeys.空气中暴露于中等大小的尼帕病毒粒子可引起非洲绿猴发生神经疾病。
PLoS Negl Trop Dis. 2018 Nov 21;12(11):e0006978. doi: 10.1371/journal.pntd.0006978. eCollection 2018 Nov.
8
Outbreak Investigation of Nipah Virus Disease in Kerala, India, 2018.2018 年印度喀拉拉邦尼帕病毒病疫情爆发调查。
J Infect Dis. 2019 May 24;219(12):1867-1878. doi: 10.1093/infdis/jiy612.
9
Emerging trends of Nipah virus: A review.尼帕病毒的研究进展:综述。
Rev Med Virol. 2019 Jan;29(1):e2010. doi: 10.1002/rmv.2010. Epub 2018 Sep 24.
10
Product Development Under FDA's Animal Rule: Understanding FDA's Expectations and Potential Implications for Traditional Development Programs.美国食品药品监督管理局动物规则下的产品开发:了解美国食品药品监督管理局的期望以及对传统开发项目的潜在影响。
Ther Innov Regul Sci. 2016 Sep;50(5):660-670. doi: 10.1177/2168479016641717. Epub 2016 Jul 10.